KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Work In Process (2016 - 2022)

Historic Work In Process for Bio-Rad Laboratories (BIO) over the last 14 years, with Q2 2022 value amounting to $158.8 million.

  • Bio-Rad Laboratories' Work In Process rose 688.35% to $158.8 million in Q2 2022 from the same period last year, while for Jun 2022 it was $158.8 million, marking a year-over-year increase of 688.35%. This contributed to the annual value of $142.7 million for FY2021, which is 604.81% down from last year.
  • As of Q2 2022, Bio-Rad Laboratories' Work In Process stood at $158.8 million, which was up 688.35% from $153.2 million recorded in Q1 2022.
  • Bio-Rad Laboratories' Work In Process' 5-year high stood at $158.8 million during Q2 2022, with a 5-year trough of $140.9 million in Q2 2018.
  • Over the past 5 years, Bio-Rad Laboratories' median Work In Process value was $148.9 million (recorded in 2018), while the average stood at $148.4 million.
  • In the last 5 years, Bio-Rad Laboratories' Work In Process skyrocketed by 1288.5% in 2018 and then plummeted by 816.89% in 2021.
  • Over the past 5 years, Bio-Rad Laboratories' Work In Process (Quarter) stood at $145.1 million in 2018, then grew by 0.74% to $146.1 million in 2019, then grew by 3.97% to $151.9 million in 2020, then decreased by 6.05% to $142.7 million in 2021, then increased by 11.25% to $158.8 million in 2022.
  • Its Work In Process was $158.8 million in Q2 2022, compared to $153.2 million in Q1 2022 and $142.7 million in Q4 2021.